 A systematic review found that lowering the cost of HPV vaccination, with or without perhaps mere screening, is cost-effective in reducing cervical cancer burden in low and middle income countries, LMICs, where the majority of the current cervical cancer cases occur. This article was authored by Ludbinger Akindil Silas, Chad J. Eckenbach, Robert Leo Murphy and others.